MLYS
NASDAQ · Biotechnology
Mineralys Therapeutics Inc
$25.78
+0.26 (+1.02%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-18.78%
1Y
+100.31%
YTD
-27.81%
Open$25.80
Previous Close$25.52
Day High$26.06
Day Low$24.95
52W High$47.65
52W Low$12.59
Volume—
Avg Volume610.3K
Market Cap2.31B
P/E Ratio—
EPS$-2.06
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$33.44
Below
SMA 200
$27.93
Below
RSI (14)
35
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
+261.5% upside
Current
$25.78
$25.78
Target
$93.19
$93.19
$50.31
$93.19 avg
$121.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 422.84M | 383.53M | 332.94M |
| Net Income | 48.98M | 43.51M | 33.06M |
| Profit Margin | 11.6% | 11.3% | 9.9% |
| EBITDA | 63.20M | 67.45M | 57.44M |
| Free Cash Flow | 26.85M | 26.46M | 31.26M |
| Rev Growth | +5.2% | +16.0% | +2.3% |
| Debt/Equity | 0.29 | 0.28 | 0.28 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $244.33 | -0.76% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $403.48 | -1.07% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $129.97 | -1.36% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $484.53 | -0.06% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $767.54 | -0.14% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.83 | -4.76% | 47.7 | 27.52B |